- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Price not available for RHP:GR
Snapshot for Amsterdam Molecular Therapeutics Holding (RHP)
| Open: | - | Day's Range: | - | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 0.003 | 52wk Range: | - | 1-Yr Rtn: | - |
Key Statistics for RHP
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2012) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS (12/2012) | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | - |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | - |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for RHP
No data available
Company Profile & Key Executives for RHP
Amsterdam Molecular Therapeutics Holding is a biotechnology company. The Company researches treatments for metabolic disorders, ocular diseases, and central and peripheral nervous system conditions.
| Jorn AldagChief Executive Officer | Piers J MorganCFO/Member-Mgmt Board |
| Carlos R CamozziChief Medical Officer | Janneke De WalMember-Mgmt Board |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
RHP News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page